Elisa Baldelli

2.5k total citations
34 papers, 545 citations indexed

About

Elisa Baldelli is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Spectroscopy. According to data from OpenAlex, Elisa Baldelli has authored 34 papers receiving a total of 545 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Spectroscopy. Recurrent topics in Elisa Baldelli's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Advanced Proteomics Techniques and Applications (6 papers) and Advanced Biosensing Techniques and Applications (6 papers). Elisa Baldelli is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Advanced Proteomics Techniques and Applications (6 papers) and Advanced Biosensing Techniques and Applications (6 papers). Elisa Baldelli collaborates with scholars based in United States, Italy and Ukraine. Elisa Baldelli's co-authors include Lucio Crinò, Vienna Ludovini, Fortunato Bianconi, Mariaelena Pierobon, Antonella Flacco, Annamaria Siggillino, Rita Chiari, Francesca Romana Tofanetti, Lorenza Pistola and Emanuel F. Petricoin and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Elisa Baldelli

33 papers receiving 534 citations

Peers

Countries citing papers authored by Elisa Baldelli

Since Specialization

Citations

This map shows the geographic impact of Elisa Baldelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisa Baldelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisa Baldelli more than expected).

Fields of papers citing papers by Elisa Baldelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisa Baldelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisa Baldelli. The network helps show where Elisa Baldelli may publish in the future.

Co-authorship network of co-authors of Elisa Baldelli

This figure shows the co-authorship network connecting the top 25 collaborators of Elisa Baldelli. A scholar is included among the top collaborators of Elisa Baldelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisa Baldelli. Elisa Baldelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Functional activation of the AKT-mTOR signalling axis in a real-world metastatic breast cancer cohort 2024 ·British Journal of Cancer ·(unknown), Elisa Baldelli, Edik M. Blais, (unknown), (unknown), Claudius Mueller, (unknown), (unknown), (unknown), (unknown), (unknown), Emanuel F. Petricoin, Wei Qi, Mariaelena Pierobon	2
2	Signaling dynamics in coexisting monoclonal cell subpopulations unveil mechanisms of resistance to anti-cancer compounds 2024 ·Cell Communication and Signaling ·(unknown), (unknown), (unknown), (unknown), (unknown), Masoumeh Sikaroodi, Ylenia Chiari, (unknown), (unknown), Virginia Espina, Emanuel F. Petricoin, Elisa Baldelli, Mariaelena Pierobon	2
3	RHOA^L57Vdrives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling 2023 ·Science Signaling ·Antje Schaefer, Richard G. Hodge, Haisheng Zhang, G. Aaron Hobbs, Julien Dilly, (unknown), Craig M. Goodwin, (unknown), J. Nathaniel Diehl, Mariaelena Pierobon, Elisa Baldelli, (unknown), K M Guthrie, Naim U. Rashid, Emanuel F. Petricoin, Adrienne D. Cox, William C. Hahn, Andrew J. Aguirre, (unknown), Channing J. Der	5
4	AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers 2023 ·npj Precision Oncology ·Maysa Abu‐Khalaf, (unknown), Christos Hatzis, Elisa Baldelli, (unknown), (unknown), William M. Sikov, Monica Mita, Neelima Denduluri, (unknown), Daniel Zelterman, Lance A. Liotta, (unknown), (unknown), Emanuel F. Petricoin, Mariaelena Pierobon	21
5	Genetically manipulating endogenous Kras levels and oncogenic mutations in vivo influences tissue patterning of murine tumorigenesis 2022 ·eLife ·(unknown), Nicole L. Pershing, Erin Kaltenbrun, (unknown), Jeffrey I. Everitt, Elisa Baldelli, Mariaelena Pierobon, Emanuel F. Petricoin, Christopher M. Counter	7
6	Analysis of neuroendocrine clones in NSCLCs using an immuno-guided laser-capture microdissection-based approach 2022 ·Cell Reports Methods ·Elisa Baldelli, Martina Mandarano, Guido Bellezza, Emanuel F. Petricoin, Mariaelena Pierobon	1
7	Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN 2021 ·Journal of Experimental & Clinical Cancer Research ·Marta Codrich, Emiliano Dalla, Catia Mio, Giulia Antoniali, Matilde Clarissa Malfatti, Stefania Marzinotto, Mariaelena Pierobon, Elisa Baldelli, Carla Di Loreto, Giuseppe Damante, Giovanni Terrosu, Carlo Pucillo, Gianluca Tell	36
8	The KRAS-regulated kinome identifies WEE1 and ERK coinhibition as a potential therapeutic strategy in KRAS-mutant pancreatic cancer 2021 ·Journal of Biological Chemistry ·J. Nathaniel Diehl, Jennifer E. Klomp, (unknown), Priya S. Hibshman, Devon R. Blake, (unknown), Thomas S.K. Gilbert, Elisa Baldelli, Mariaelena Pierobon, Bjoern Papke, Runying Yang, Richard G. Hodge, Naim U. Rashid, Emanuel F. Petricoin, Laura E. Herring, Lee M. Graves, Adrienne D. Cox, Channing J. Der	21
9	The impact of ultraviolet- and infrared-based laser microdissection technology on phosphoprotein detection in the laser microdissection-reverse phase protein array workflow 2020 ·Clinical Proteomics ·Allison L. Hunt, Mariaelena Pierobon, Elisa Baldelli, Julie Oliver, (unknown), (unknown), Nicholas W. Bateman, G. Larry Maxwell, Emanuel F. Petricoin, Thomas P. Conrads	6
10	Abstract 3129: PD-L1 expression differs across cancer metastatic sites from breast tumors 2018 ·Cancer Research ·Mariaelena Pierobon, (unknown), Elisa Baldelli, (unknown), Nicholas J. Robert, Donald W. Northfelt, Mohammad Jahanzeb, (unknown), Lance A. Liotta, (unknown), Emanuel F. Petricoin	1
11	Kinase-driven metabolic signalling as a predictor of response to carboplatin–paclitaxel adjuvant treatment in advanced ovarian cancers 2017 ·British Journal of Cancer ·(unknown), Elisa Baldelli, Guido Gambara, Antonella Ravaggi, (unknown), David S. Alberts, José Guillen-Rodriguez, Ting Dong, Maurizio Memo, Franco Odicino, Roberto Angioli, Lance A. Liotta, Sërgio Pecorelli, Emanuel F. Petricoin, Mariaelena Pierobon	10
12	Reverse Phase Protein Microarrays 2017 ·Methods in molecular biology ·Elisa Baldelli, Valerie Calvert, Alex Hodge, Amy VanMeter, Emanuel F. Petricoin, Mariaelena Pierobon	39
13	A pilot study exploring the molecular architecture of the tumor microenvironment in human prostate cancer using laser capture microdissection and reverse phase protein microarray 2016 ·Molecular Oncology ·Elisa Pin, Steven P. Stratton, Claudio Belluco, Lance A. Liotta, Ray B. Nagle, (unknown), Jianghong Deng, Ting Dong, Elisa Baldelli, Emanuel F. Petricoin, Mariaelena Pierobon	18
14	Functional signaling pathway analysis of lung adenocarcinomas identifies novel therapeutic targets for KRAS mutant tumors 2015 ·Oncotarget ·Elisa Baldelli, Guido Bellezza, Eric B. Haura, Lucio Crinò, W. Douglas Cress, Jianghong Deng, Vienna Ludovini, Angelo Sidoni, Matthew B. Schabath, Francesco Puma, Jacopo Vannucci, Annamaria Siggillino, Lance A. Liotta, Emanuel F. Petricoin, Mariaelena Pierobon	13
15	Conditional robustness analysis for fragility discovery and target identification in biochemical networks and in cancer systems biology 2015 ·BMC Systems Biology ·Fortunato Bianconi, Elisa Baldelli, (unknown), Emanuel F. Petricoin, Lucio Crinò, Paolo Valigi	10
16	Concomitant high gene copy number and protein overexpression of IGF1R and EGFR negatively affect disease-free survival of surgically resected non-small-cell-lung cancer patients 2013 ·Cancer Chemotherapy and Pharmacology ·Vienna Ludovini, Antonella Flacco, Fortunato Bianconi, Mark Ragusa, Jacopo Vannucci, Guido Bellezza, Rita Chiari, V. Minotti, Lorenza Pistola, Francesca Romana Tofanetti, Annamaria Siggillino, Elisa Baldelli, Angelo Sidoni, Niccolò Daddi, Francesco Puma, Marileila Varella‐Garcia, Lucio Crinò	14
17	Robustness of complex feedback systems: application to oncological biochemical networks 2013 ·International Journal of Control ·Fortunato Bianconi, Elisa Baldelli, Vienna Ludovini, Lucio Crinò, Katia Perruccio, Paolo Valigi	5
18	Optimization of patient selection for EGFR-TKIs in advanced non-small cell lung cancer by combined analysis of KRAS, PIK3CA, MET, and non-sensitizing EGFR mutations 2012 ·Cancer Chemotherapy and Pharmacology ·Vienna Ludovini, Fortunato Bianconi, Lorenza Pistola, V. Minotti, Rita Chiari, Renato Colella, Guido Bellezza, Francesca Romana Tofanetti, Annamaria Siggillino, Elisa Baldelli, Antonella Flacco, Dario Giuffrida, Angelo Sidoni, Lucio Crinò	35
19	Phosphoinositide-3-Kinase Catalytic Alpha and KRAS Mutations are Important Predictors of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients with Advanced Non-small Cell Lung Cancer 2011 ·Journal of Thoracic Oncology ·Vienna Ludovini, Fortunato Bianconi, Lorenza Pistola, Rita Chiari, Vincenzo Minotti, Renato Colella, Dario Giuffrida, Francesca Romana Tofanetti, Annamaria Siggillino, Antonella Flacco, Elisa Baldelli, Daniela Iacono, Maria Grazia Mameli, Antonio Cavaliere, Lucio Crinò	145
20	Computational model of EGFR and IGF1R pathways in lung cancer: A Systems Biology approach for Translational Oncology 2011 ·Biotechnology Advances ·Fortunato Bianconi, Elisa Baldelli, Vienna Ludovini, Lucio Crinò, Antonella Flacco, Paolo Valigi	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact